Most breast cancer patients do not have breast reconstruction surgery

Only seven per cent of female breast cancer patients opt for breast reconstruction surgery.

Dr. Melinda Musgrave is determined to find out why.

"Reconstruction has a very positive effort on these women as they go through their breast cancer journey," said Dr. Musgrave, a at St. Michael's Hospital. "The problem is that it's still seen as cosmetic or unnecessary and it needs to be brought into the correct light."

Other reasons women don't get reconstruction range from doctor's that it affects a women's risk of cancer recurring, to patient concerns that having reconstruction makes them appear vain or is too much of a psychological hurdle after their last operation to remove their cancer, she said.

The Canadian Breast Cancer Foundation recently awarded Dr. Musgrave $188,180 to explore these factors over two years, specifically whether physician attitudes play a role in women's decision-making about reconstruction.

Dr. Musgrave hopes to draw attention to the benefits of reconstructive surgery today at an event at St. Michael's that is part of National Awareness (BRA) Day – an initiative designed to promote education, awareness and access for women who may wish to consider post-mastectomy breast reconstruction.

BRA Day will be celebrated by reconstructive surgeons across the country at their respective hospitals. Today at St. Michael's, women can see what options they have to restore their breast after surgery, participate in an interactive lecture about the key questions in and hear four of Dr. Musgrave's patients talk about their breast cancer journey and their decision to have reconstruction.

One young patient will tell her story of how after having a mastectomy, breast reconstruction and chemo, she was able to have a baby.

BRA Day organizer say their vision is that prior to undergoing treatment, all women will be offered information about the options for reconstructive breast surgery and be provided access to breast reconstruction in a safe and timely manner.

Provided by St. Michael's Hospital

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Are breast cancer patients being kept in the dark?

Jul 07, 2009

Despite the increase of breast reconstruction procedures performed in 2008, nearly 70 percent of women who are eligible for the procedure are not informed of the reconstructive options available to them, according to a recently ...

Recommended for you

Renewed hope in a once-abandoned cancer drug class

3 hours ago

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

Finding the way to lung tumours by 'GPS'

5 hours ago

The innumerable divisions of the bronchi often turn the hunt for tumours in the lungs into a game of chance. But soon, lung specialists will be able to navigate accurately inside the airways by "GPS".

Study suggests new approach to fight lung cancer

19 hours ago

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.